Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trinity Biotech (TRIB) Non-Current Deferred Tax Liability (2016 - 2024)

Trinity Biotech (TRIB) has disclosed Non-Current Deferred Tax Liability for 9 consecutive years, with $4.6 million as the latest value for Q4 2024.

  • Quarterly Non-Current Deferred Tax Liability rose 98.3% to $4.6 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $4.6 million through Dec 2024, up 98.3% year-over-year, with the annual reading at $4.6 million for FY2024, 98.3% up from the prior year.
  • Non-Current Deferred Tax Liability hit $4.6 million in Q4 2024 for Trinity Biotech, up from $2.3 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $5.1 million in Q4 2022 to a low of $2.3 million in Q4 2023.
  • Historically, Non-Current Deferred Tax Liability has averaged $4.3 million across 5 years, with a median of $4.9 million in 2021.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: crashed 54.53% in 2023 and later soared 98.3% in 2024.
  • Year by year, Non-Current Deferred Tax Liability stood at $4.9 million in 2020, then decreased by 0.96% to $4.9 million in 2021, then grew by 4.12% to $5.1 million in 2022, then plummeted by 54.53% to $2.3 million in 2023, then soared by 98.3% to $4.6 million in 2024.
  • Business Quant data shows Non-Current Deferred Tax Liability for TRIB at $4.6 million in Q4 2024, $2.3 million in Q4 2023, and $5.1 million in Q4 2022.